Status:
COMPLETED
Detection of COVID-19 Using Breath Analysis - Validation Study.
Lead Sponsor:
Scentech Medical Technologies Ltd
Conditions:
COVID-19
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Detection of the 2019 novel Coronavirus (SARS-CoV-2) using breath analysis - Validation study.
Detailed Description
A diagnostic prospective single-site study, with no anticipated risks or constraints. Primary objective- To validate the value of a set of breath VOC biomarkers that enable the investigator to distin...
Eligibility Criteria
Inclusion
- Age 18 to 75 years at the time of consent
- Capable of understanding written and/or spoken language
- Able to provide informed consent
- Was not treated with Anti-viral drugs
Exclusion
- Age under 18 years old
- Under guardianship or deprived of liberty
- Pregnant or lactating woman
Key Trial Info
Start Date :
January 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 18 2023
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT05224622
Start Date
January 18 2022
End Date
January 18 2023
Last Update
May 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Poriya Medical Center
Poria – Neve Oved, Israel, 1528001